Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2014 1
2017 1
2018 2
2019 1
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Dosing regimen optimisation for oseltamivir in immunocompromised paediatric patients with influenza: Extrapolation of efficacy.
Jordie EB, Gibiansky L, Knab T, Lemenuel-Diot A, Ravva P, Zwanziger E, Jolivet S, Bhardwaj R, Hernández-Sánchez J, Nasmyth-Miller C, Sturm S. Jordie EB, et al. Among authors: nasmyth miller c. Br J Clin Pharmacol. 2022 Mar;88(3):1189-1201. doi: 10.1111/bcp.15059. Epub 2021 Oct 15. Br J Clin Pharmacol. 2022. PMID: 34449090 Free article.
Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza.
Bautista F, Engelhard D, Rizzari C, Baka M, Saavedra-Lozano J, Lopez-Medina E, Nasmyth-Miller C, Hernández-Sánchez J, Sturm S. Bautista F, et al. Among authors: nasmyth miller c. Open Forum Infect Dis. 2019 Oct 23;6(10):ofz430. doi: 10.1093/ofid/ofz430. eCollection 2019 Oct. Open Forum Infect Dis. 2019. PMID: 31660381 Free PMC article.
Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimization.
Sturm S, Lemenuel-Diot A, Patel K, Gibiansky L, Bhardwaj R, Smith PF, Dang S, Zwanziger E, Nasmyth-Miller C, Ravva P. Sturm S, et al. Among authors: nasmyth miller c. Br J Clin Pharmacol. 2021 Mar;87(3):1359-1368. doi: 10.1111/bcp.14523. Epub 2020 Sep 9. Br J Clin Pharmacol. 2021. PMID: 32808306 Free PMC article.
Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
Kivitz A, Olech E, Borofsky MA, Zazueta B, Navarro-Sarabia F, Radominski SC, Merrill JT, Pacheco-Tena C, Pei J, Nasmyth-Miller C, Pope JE. Kivitz A, et al. Among authors: nasmyth miller c. J Rheumatol. 2018 Apr;45(4):456-464. doi: 10.3899/jrheum.161539. Epub 2017 Dec 15. J Rheumatol. 2018. PMID: 29247149 Free article. Clinical Trial.
Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Kivitz A, Olech E, Borofsky M, Zazueta BM, Navarro-Sarabia F, Radominski SC, Merrill JT, Rowell L, Nasmyth-Miller C, Bao M, Wright S, Pope JE. Kivitz A, et al. Among authors: nasmyth miller c. Arthritis Care Res (Hoboken). 2014 Nov;66(11):1653-61. doi: 10.1002/acr.22384. Arthritis Care Res (Hoboken). 2014. PMID: 24942540 Free PMC article. Clinical Trial.
Association of four DNA polymorphisms with acute rejection after kidney transplantation.
Grinyó J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, Rashford M, Nasmyth-Miller C, Voulgari A, Spleiss O, Truman M, Essioux L. Grinyó J, et al. Among authors: nasmyth miller c. Transpl Int. 2008 Sep;21(9):879-91. doi: 10.1111/j.1432-2277.2008.00679.x. Epub 2008 Apr 25. Transpl Int. 2008. PMID: 18444945 Free article.
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study. Am J Transplant 7, 560-570, 2007.
Ekberg H, Grinyo J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M; CAESAR study group. Ekberg H, et al. Among authors: nasmyth miller c. Clin J Am Soc Nephrol. 2008 Jan;3(1):7-9. doi: 10.2215/01.CJN.0000926944.30910.72. Clin J Am Soc Nephrol. 2008. PMID: 37001118 No abstract available.